Literature DB >> 28256011

Population-Wide Impact of Non-Hip Non-Vertebral Fractures on Mortality.

Thach Tran1, Dana Bliuc1, Tineke van Geel2, Jonathan D Adachi3, Claudie Berger4, Joop van den Bergh5,6, John A Eisman1,7,8,9,10, Piet Geusens11,12, David Goltzman13, David A Hanley14, Robert G Josse15, Stephanie M Kaiser16, Christopher S Kovacs17, Lisa Langsetmo18, Jerilynn C Prior19, Tuan V Nguyen1,8, Jacqueline R Center1,7,8.   

Abstract

Data on long-term consequences of non-hip non-vertebral (NHNV) fractures, accounting for approximately two-thirds of all fragility fractures, are scanty. Our study aimed to quantify the population-wide impact of NHNV fractures on mortality. The national population-based prospective cohort study (Canadian Multicentre Osteoporosis Study) included 5526 community dwelling women and 2163 men aged 50 years or older followed from July 1995 to September 2013. Population impact number was used to quantify the average number of people for whom one death would be attributable to fracture and case impact number to quantify the number of deaths out of which one would be attributable to a fracture. There were 1370 fragility fractures followed by 296 deaths in women (mortality rate: 3.49; 95% CI, 3.11 to 3.91), and 302 fractures with 92 deaths in men (5.05; 95% CI, 4.12 to 6.20). NHNV fractures accounted for three-quarters of fractures. In women, the population-wide impact of NHNV fractures on mortality was greater than that of hip and vertebral fractures because of the greater number of NHNV fractures. Out of 800 women, one death was estimated to be attributable to a NHNV fracture, compared with one death in 2000 women attributable to hip or vertebral fracture. Similarly, out of 15 deaths in women, one was estimated to be attributable to a NHNV fracture, compared with one in over 40 deaths for hip or vertebral fracture. The impact of forearm fractures (ie, one death in 2400 women and one out of 42 deaths in women attributable to forearm fracture) was similar to that of hip, vertebral, or rib fractures. Similar, albeit not significant, results were noted for men. The study highlights the important contribution of NHNV fractures on mortality because many NHNV fracture types, except for the most distal fractures, have serious adverse consequences that affect a significant proportion of the population.
© 2017 American Society for Bone and Mineral Research. © 2017 American Society for Bone and Mineral Research.

Entities:  

Keywords:  AGING; EPIDEMIOLOGY; PRACTICE/POLICY-RELATED ISSUES

Mesh:

Year:  2017        PMID: 28256011     DOI: 10.1002/jbmr.3118

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  15 in total

1.  Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS.

Authors:  A Svedbom; F Borgstöm; E Hernlund; O Ström; V Alekna; M L Bianchi; P Clark; M D Curiel; H P Dimai; M Jürisson; R Kallikorm; M Lember; O Lesnyak; E McCloskey; K M Sanders; S Silverman; A Solodovnikov; M Tamulaitiene; T Thomas; N Toroptsova; A Uusküla; A N A Tosteson; B Jönsson; J A Kanis
Journal:  Osteoporos Int       Date:  2017-12-11       Impact factor: 4.507

2.  EVALUATION OF MANAGEMENT OF PATIENTS WITH OSTEOPOROTIC FRACTURES BY ORTHOPEDIC RESIDENTS: A CROSS-SECTIONAL OBSERVATIONAL STUDY.

Authors:  Guilherme Pereira Ocampos; Matheus Mendonça Peres; Marcia Uchoa de Rezende; Matheus Manolo Arouca; Olavo Pires de Camargo
Journal:  Acta Ortop Bras       Date:  2022-07-06       Impact factor: 0.683

Review 3.  Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

Authors:  George A Wells; Shu-Ching Hsieh; Carine Zheng; Joan Peterson; Peter Tugwell; Wenfei Liu
Journal:  Cochrane Database Syst Rev       Date:  2022-05-03

4.  Impact of osteoporotic fracture type and subsequent fracture on mortality: the Tromsø Study.

Authors:  D Alarkawi; D Bliuc; T Tran; L A Ahmed; N Emaus; A Bjørnerem; L Jørgensen; T Christoffersen; J A Eisman; J R Center
Journal:  Osteoporos Int       Date:  2019-10-26       Impact factor: 4.507

5.  Does osteoporosis affect the healing of subcapital humerus and distal radius fractures?

Authors:  E A Gorter; B M Gerretsen; P Krijnen; N M Appelman-Dijkstra; I B Schipper
Journal:  J Orthop       Date:  2020-05-06

6.  PROFILE OF PATIENTS WITH OSTEOPOROTIC FRACTURES AND FACTORS THAT DECREASE PREVENTION.

Authors:  Renato Martins Xavier; Ivan Carvalho Giarola; Guilherme Pereira Ocampos; Pérola Grinberg Plapler; Olavo Pires de Camargo; Márcia Uchôa de Rezende
Journal:  Acta Ortop Bras       Date:  2019 Mar-Apr       Impact factor: 0.513

7.  All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture.

Authors:  I J A de Bruin; C Klop; C E Wyers; J A Overbeek; P P M M Geusens; J P W van den Bergh; J H M Driessen; F de Vries
Journal:  Osteoporos Int       Date:  2019-02-08       Impact factor: 4.507

8.  NOTUM inhibition increases endocortical bone formation and bone strength.

Authors:  Robert Brommage; Jeff Liu; Peter Vogel; Faika Mseeh; Andrea Y Thompson; David G Potter; Melanie K Shadoan; Gwenn M Hansen; Sabrina Jeter-Jones; Jie Cui; Dawn Bright; Jennifer P Bardenhagen; Deon D Doree; Sofia Movérare-Skrtic; Karin H Nilsson; Petra Henning; Ulf H Lerner; Claes Ohlsson; Arthur T Sands; James E Tarver; David R Powell; Brian Zambrowicz; Qingyun Liu
Journal:  Bone Res       Date:  2019-01-08       Impact factor: 13.567

9.  Refracture and mortality following hospitalization for severe osteoporotic fractures: The Fractos Study.

Authors:  Christian Roux; Thierry Thomas; Julien Paccou; Geoffray Bizouard; Anne Crochard; Emese Toth; Magali Lemaitre; Frédérique Maurel; Laure Perrin; Florence Tubach
Journal:  JBMR Plus       Date:  2021-05-14

Review 10.  The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis.

Authors:  N Li; M Hiligsmann; A Boonen; M M van Oostwaard; R T A L de Bot; C E Wyers; S P G Bours; J P van den Bergh
Journal:  Osteoporos Int       Date:  2021-04-07       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.